Abdullaat S. Kadyrov

Bishkek, GB, Kyrgyzstan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Community-led monitoring of TB services in the Kyrgyz Republic.

Community-led monitoring of TB services in the Kyrgyz Republic.

Journal: IJTLD open
Published: November 07, 2025

Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort study.

Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort study.

Journal: The Lancet regional health. Europe
Published: April 07, 2025

Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan - a phenomenological study.

Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan - a phenomenological study.

Journal: International journal for equity in health
Published: February 22, 2025

Further effort is needed to avoid irrational use after drug susceptibility testing for drug-resistant TB.

Further effort is needed to avoid irrational use after drug susceptibility testing for drug-resistant TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: January 04, 2025

Whole-genome sequencing drug susceptibility testing is associated with positive MDR-TB treatment response.

Whole-genome sequencing drug susceptibility testing is associated with positive MDR-TB treatment response.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: September 28, 2024

Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan.

Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan.

Journal: Journal of clinical tuberculosis and other mycobacterial diseases
Published: August 23, 2024

Strengthening the Operational Research Capacity of National Tuberculosis Control Programs: Necessity or Luxury?

Strengthening the Operational Research Capacity of National Tuberculosis Control Programs: Necessity or Luxury?

Journal: Tropical medicine and infectious disease
Published: June 16, 2023

Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021.

Time to Treatment and Risk Factors for Unsuccessful Treatment Outcomes among People Who Started Second-Line Treatment for Rifampicin-Resistant or Multi-Drug-Resistant Tuberculosis in the Kyrgyz Republic, 2021.

Journal: Tropical medicine and infectious disease
Published: June 06, 2023

Contact Tracing and Tuberculosis Preventive Therapy for Household Child Contacts of Pulmonary Tuberculosis Patients in the Kyrgyz Republic: How Well Are We Doing?

Contact Tracing and Tuberculosis Preventive Therapy for Household Child Contacts of Pulmonary Tuberculosis Patients in the Kyrgyz Republic: How Well Are We Doing?

Journal: Tropical medicine and infectious disease
Published: May 21, 2023

Triple Priority: TB/HIV Co-Infection and Treatment Outcomes among Key Populations in The Kyrgyz Republic: A National Cohort Study (2018-2022).

Triple Priority: TB/HIV Co-Infection and Treatment Outcomes among Key Populations in The Kyrgyz Republic: A National Cohort Study (2018-2022).

Journal: Tropical medicine and infectious disease
Published: May 18, 2023

"Together against Tuberculosis": Cascade of Care of Patients Referred by the Private Health Care Providers in the Kyrgyz Republic.

"Together against Tuberculosis": Cascade of Care of Patients Referred by the Private Health Care Providers in the Kyrgyz Republic.

Journal: Tropical medicine and infectious disease
Published: May 11, 2023

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis.

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis.

Journal: BMJ global health
Published: August 12, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026